Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 69.34% is 150% above its 5-year average of -138.99%, near the high end of its 5-year range (-776.23%–211.39%).
86.07% above its 12-month average of 37.27%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1.59%.
NET PROFIT MARGIN
69.34%
NET PROFIT MARGIN AVG TTM
37.27%
NET PROFIT MARGIN AVG 3Y
-106.50%
NET PROFIT MARGIN AVG 5Y
-138.99%
NET PROFIT MARGIN AVG 10Y
-188.10%
NET PROFIT MARGIN AVG 15Y
-350.39%
NET PROFIT MARGIN AVG 20Y
-498.51%
CURRENT VS TTM AVG
+86.07%
CURRENT VS 3Y AVG
+165.11%
CURRENT VS 5Y AVG
+149.89%
CURRENT VS 10Y AVG
+136.86%
CURRENT VS 15Y AVG
+119.79%
CURRENT VS 20Y AVG
+113.91%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+26769.23%
vs the sector median at left
Agenus Inc.
Market Cap
$315.02M
Net Profit Margin
69.34%
TTM Avg
37.27%
3Y Avg
-106.50%
5Y Avg
-138.99%
Market Cap
$310.69M
Net Profit Margin
-289.44%
TTM Avg
-294.02%
3Y Avg
-409.64%
5Y Avg
-336.94%
Market Cap
$309.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6520.67%
5Y Avg
-12425.66%
Market Cap
$321.09M
Net Profit Margin
-56.96%
TTM Avg
-82.06%
3Y Avg
-78.03%
5Y Avg
-79.87%
Market Cap
$321.76M
Net Profit Margin
-29.15%
TTM Avg
-23.79%
3Y Avg
-17.88%
5Y Avg
-22.05%
Market Cap
$325.26M
Net Profit Margin
-214.74%
TTM Avg
-178.01%
3Y Avg
-157.31%
5Y Avg
-157.31%
Market Cap
$327.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$329.89M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
Market Cap
$292.92M
Net Profit Margin
-145.12%
TTM Avg
-145.12%
3Y Avg
-145.12%
5Y Avg
-145.12%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agenus Inc. (AGEN) | $315.02M | 69.34% | 37.27% | -106.50% | -138.99% |
| C4 Therapeutics, Inc. (CCCC)vs › | $310.69M | -289.44% | -294.02% | -409.64% | -336.94% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.88M | 0.00% | 0.00% | -6520.67% | -12425.66% |
| Avita Medical Inc. (RCEL)vs › | $321.09M | -56.96% | -82.06% | -78.03% | -79.87% |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | -29.15% | -23.79% | -17.88% | -22.05% |
| CapsoVision, Inc. (CV)vs › | $325.26M | -214.74% | -178.01% | -157.31% | -157.31% |
| Cabaletta Bio, Inc. (CABA)vs › | $327.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $329.89M | -81.76% | -64.66% | -75.38% | -73.80% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.92M | -145.12% | -145.12% | -145.12% | -145.12% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $289.96M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-18.0%
Net Profit Margin
69.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1.59% |
| 2026-03-31 | 116.27% |
| 2025-12-31 | -30.93% |
| 2025-09-30 | 211.39% |
| 2025-06-30 | -108.81% |
| 2025-03-31 | -104.99% |
| 2024-12-31 | -170.88% |
| 2024-09-30 | -264.36% |
| 2024-06-30 | -225.79% |
| 2024-03-31 | -220.98% |
| 2023-12-31 | -55.24% |
| 2023-09-30 | -255.82% |
| 2023-06-30 | -272.83% |
| 2023-03-31 | -298.03% |
| 2022-12-31 | -197.09% |
| 2022-09-30 | -238.11% |
| 2022-06-30 | -221.90% |
| 2022-03-31 | -186.29% |
| 2021-12-31 | -323.34% |
| 2021-09-30 | 69.58% |
| 2021-06-30 | -776.23% |
| 2021-03-31 | -458.03% |
| 2020-12-31 | -120.29% |
| 2020-09-30 | -344.88% |
| 2020-06-30 | -176.21% |
| 2020-03-31 | -295.31% |
| 2019-12-31 | -87.12% |
| 2019-09-30 | -228.05% |
| 2019-06-30 | -322.20% |
| 2019-03-31 | 23.16% |
| 2018-12-31 | -740.33% |
| 2018-09-30 | -258.75% |
| 2018-06-30 | -155.22% |
| 2018-03-31 | -3309.24% |
| 2017-12-31 | -419.38% |
| 2017-09-30 | -1096.68% |
| 2017-06-30 | -753.82% |
| 2017-03-31 | -63.45% |
| 2016-12-31 | -468.49% |
| 2016-09-30 | -917.07% |
| 2016-06-30 | -429.61% |
| 2016-03-31 | -533.29% |
| 2015-12-31 | -204.31% |
| 2015-09-30 | -191.62% |
| 2015-06-30 | -633.68% |
| 2015-03-31 | -474.12% |
| 2014-12-31 | -1604.57% |
| 2014-09-30 | -518.71% |
| 2014-06-30 | -252.50% |
| 2014-03-31 | -49.65% |
| 2013-12-31 | -1469.97% |
| 2013-09-30 | -994.43% |
| 2013-06-30 | -1380.67% |
| 2013-03-31 | -526.15% |
| 2012-12-31 | -499.08% |
| 2012-09-30 | -659.26% |
| 2012-06-30 | -1104.15% |
| 2012-03-31 | 50.60% |
| 2011-12-31 | -935.17% |
| 2011-09-30 | -846.65% |
| 2011-06-30 | -732.44% |
| 2011-03-31 | -887.62% |
| 2010-12-31 | -243.17% |
| 2010-09-30 | -913.99% |
| 2010-06-30 | -617.48% |
| 2010-03-31 | -940.92% |
| 2009-12-31 | 340.08% |
| 2009-09-30 | -1183.83% |
| 2009-06-30 | -951.92% |
| 2009-03-31 | -1525.12% |
| 2008-12-31 | 1008.25% |
| 2008-09-30 | -1596.89% |
| 2008-06-30 | -2010.03% |
| 2008-03-31 | -1302.10% |
| 2007-12-31 | -835.10% |
| 2007-09-30 | -1250.40% |
| 2007-06-30 | -682.50% |
| 2007-03-31 | -369.62% |
| 2006-12-31 | -3608.18% |
| 2006-09-30 | -5091.63% |
| 2006-06-30 | -14713.77% |
| 2006-03-31 | -25311.17% |
| 2005-12-31 | -5085.45% |
| 2005-09-30 | -22545.73% |
| 2005-06-30 | -24947.77% |
| 2005-03-31 | -14957.48% |
| 2004-12-31 | -13582.73% |
| 2004-09-30 | -6543.06% |
| 2004-06-30 | -1651.23% |
| 2004-03-31 | -3834.38% |
| 2003-12-31 | -1974.26% |
| 2003-09-30 | -2221.81% |
| 2003-06-30 | -1739.89% |
| 2003-03-31 | -757.84% |
| 2002-12-31 | -2030.48% |
| 2002-09-30 | -1396.97% |
